Generic Clearance to Conduct Formative Research (NIAID)

ICR 201712-0925-002

OMB: 0925-0755

Federal Form Document

ICR Details
0925-0755 201712-0925-002
Active
HHS/NIH
Generic Clearance to Conduct Formative Research (NIAID)
New collection (Request for a new OMB Control Number)   No
Regular
Approved with change 03/12/2018
Retrieve Notice of Action (NOA) 12/11/2017
Approved consistent with the understanding that outcomes will not be employed to influence or directly inform significant policy or determination/allocation of grant funding. Outcomes are primarily intended for internal agency use in the further development of materials, resources, and projects. A full supporting statement part A and B, along with all accompanying instruments and documentation will be submitted for each information collection (IC) submitted under this generic. Any use of incentives will include a justification for the specific value proposed and its necessity in conducting the collection.
  Inventory as of this Action Requested Previously Approved
03/31/2021 36 Months From Approved
35,550 0 0
34,575 0 0
1,187,647 0 0

NIAID is requesting OMB approval for information collections to improve research approaches and final product development to identify emergent infectious disease threats and comorbidities related to the needs of diverse audiences. The National Institute of Allergy and Infectious Diseases is charged with the conduct and support of research, training, health information dissemination, and other programs with respect to allergic and immunologic diseases and disorders. The Evaluation Section of the Strategic Planning and Evaluation Branch (SPEB) at NIAID conducts various types of research, analyses, and assessments to identify and learn about target audience programmatic needs, and gaps. The activities conducted by the Evaluation Section of SPEB helps to ensure that NIAID communicates, educates, and disseminates appropriate, useful and effective resources. The information to be collected as part of this generic clearance will allow the agency to make appropriate adjustments in content and methods used in developmental and testing stages, including peer-review, in order to improve research approaches and final product development.

US Code: 42 USC 285f Name of Law: National Institute of Allergy and Infectious Diseases (NIAID)
  
None

Not associated with rulemaking

  82 FR 44631 09/25/2017
82 FR 58213 12/11/2017
No

0

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 35,550 0 0 35,550 0 0
Annual Time Burden (Hours) 34,575 0 0 34,575 0 0
Annual Cost Burden (Dollars) 1,187,647 0 0 1,187,647 0 0
Yes
Miscellaneous Actions
No
New Generic

$1,025,112
Yes Part B of Supporting Statement
    Yes
    Yes
No
No
No
Uncollected
Tawanda Abdelmouti 240 276-5530 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
12/11/2017


© 2024 OMB.report | Privacy Policy